Enterprise Financial Services Corp (EFSC)’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-28
Closed -$2K 712
2021
Q2
$2K Buy
28
+1
+4% +$76 ﹤0.01% 1127
2021
Q1
$2K Buy
27
+22
+440% +$2.03K ﹤0.01% 1139
2020
Q4
$0 Sell
5
-15
-75% -$1.83K ﹤0.01% 1324
2020
Q3
$3K Buy
20
+1
+5% +$167 ﹤0.01% 964
2020
Q2
$4K Buy
19
+10
+111% +$2.07K ﹤0.01% 891
2020
Q1
$2K Buy
+9
New +$1.94K ﹤0.01% 1007

Other funds holding LKFT

Enterprise Financial Services Corp (EFSC)'s LKFT Position: Q3 2021 in Review

Enterprise Financial Services Corp (EFSC) sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2021, closing a stake of 28 shares — an estimated $2K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in LKFT in Q1 2020 and held it in 6 quarters. The position peaked at $4K in Q2 2020. 81 funds tracked by Wall St. Rank hold LKFT as of Q3 2021.

  • Enterprise Financial Services Corp (EFSC) reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2021 after selling out during the quarter.
  • Enterprise Financial Services Corp (EFSC) sold 28 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2021, an estimated $2K.
  • Enterprise Financial Services Corp (EFSC) first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2020 and held it in 6 quarters.
  • Enterprise Financial Services Corp (EFSC)'s Lakefront Biotherapeutics American Depositary Shares position peaked at $4K in Q2 2020.
  • 81 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2021.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q3 2021, filed 15 Nov 2021.